1. Home
  2. PHAT vs BHB Comparison

PHAT vs BHB Comparison

Compare PHAT & BHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAT
  • BHB
  • Stock Information
  • Founded
  • PHAT 2018
  • BHB 1887
  • Country
  • PHAT United States
  • BHB United States
  • Employees
  • PHAT N/A
  • BHB N/A
  • Industry
  • PHAT Biotechnology: Pharmaceutical Preparations
  • BHB Major Banks
  • Sector
  • PHAT Health Care
  • BHB Finance
  • Exchange
  • PHAT Nasdaq
  • BHB Nasdaq
  • Market Cap
  • PHAT 539.5M
  • BHB 558.4M
  • IPO Year
  • PHAT 2019
  • BHB 1997
  • Fundamental
  • Price
  • PHAT $8.32
  • BHB $34.57
  • Analyst Decision
  • PHAT Strong Buy
  • BHB Hold
  • Analyst Count
  • PHAT 4
  • BHB 2
  • Target Price
  • PHAT $23.00
  • BHB $33.50
  • AVG Volume (30 Days)
  • PHAT 992.3K
  • BHB 31.4K
  • Earning Date
  • PHAT 11-07-2024
  • BHB 01-21-2025
  • Dividend Yield
  • PHAT N/A
  • BHB 3.49%
  • EPS Growth
  • PHAT N/A
  • BHB N/A
  • EPS
  • PHAT N/A
  • BHB 2.78
  • Revenue
  • PHAT $26,270,000.00
  • BHB $148,706,000.00
  • Revenue This Year
  • PHAT $7,622.43
  • BHB N/A
  • Revenue Next Year
  • PHAT $236.87
  • BHB $3.78
  • P/E Ratio
  • PHAT N/A
  • BHB $12.37
  • Revenue Growth
  • PHAT N/A
  • BHB N/A
  • 52 Week Low
  • PHAT $6.07
  • BHB $23.26
  • 52 Week High
  • PHAT $19.71
  • BHB $38.47
  • Technical
  • Relative Strength Index (RSI)
  • PHAT 36.67
  • BHB 43.51
  • Support Level
  • PHAT $7.81
  • BHB $33.65
  • Resistance Level
  • PHAT $8.56
  • BHB $36.00
  • Average True Range (ATR)
  • PHAT 0.59
  • BHB 0.95
  • MACD
  • PHAT 0.22
  • BHB -0.29
  • Stochastic Oscillator
  • PHAT 38.28
  • BHB 12.79

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

About BHB Bar Harbor Bankshares Inc.

Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. The company has following reportable segments such as Commercial construction, Commercial real estate owner occupied and non-owner occupied, Tax Exempt, Commercial and industrial loans, Residential real estate, Home equity and Consumer other. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, and fiduciary services, investment planning, education funding, individual retirement planning..

Share on Social Networks: